Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial
Author:
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
http://academic.oup.com/jnci/article-pdf/100/20/1454/7682218/djn319.pdf
Reference22 articles.
1. The epidemiology of bladder and kidney cancer
2. Epidemiologic Aspects of Renal Cell Carcinoma
3. Global Cancer Statistics, 2002
4. A case for geriatric oncology
5. Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
Cited by 118 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Inflammatory Networks in Renal Cell Carcinoma;Cancers;2023-04-09
2. Antiangiogenic drugs: Chemosensitizers for combination cancer therapy;Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy;2022
3. Outcomes based on age in patients with metastatic renal cell carcinoma treated with first line targeted therapy or checkpoint immunotherapy: Older patients more prone to toxicity;Journal of Geriatric Oncology;2021-06
4. Efficacy and safety of anti-vascular endothelial growth factor therapies in older patients for first line treatment of metastatic renal cell carcinoma;Translational Andrology and Urology;2021-06
5. Everolimus after failure of one prior VEGF ‐targeted therapy in metastatic renal cell carcinoma: Final results of the MARC ‐2 trial;International Journal of Cancer;2020-10-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3